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The Contribution of Air Pollution to the
Burden of Cardiovascular Disease
J. Patrick Mastin
Division of Extramural Research and Training
National Institute of Environmental Health and Safety
Research Triangle Park, NC.
The first people to experience the health effects of air 
pollution were undoubtedly the first people to use fire for 
cooking and staying warm.  However, it wasn’t until people 
began to live together in cities and began to burn coal and 
other fossil fuels, for industrial processes and transportation 
as well as food and warmth, that medical professions began 
to seriously consider the adverse health effects of these 
combustion products.  Now that our society and economy are 
dependent on the benefits of burning these fuels, we live in an 
atmosphere that is made up, not only of “natural” gases (such 
as nitrogen, oxygen, carbon dioxide) and aerosols (such as 
wind-borne dust), but also potentially harmful gases, such as 
ozone, aldehydes, and sulfur dioxide, and aerosols consisting 
of microscopic droplets of such chemicals as sulfates and 
nitrates and carbon particles (“soot”) to which chemicals 
such as hydrocarbons and heavy metals are adsorbed.  This 
is especially true in large metropolitan and industrial areas. 
As a result of this increase in air pollution, the biomedical 
community began, especially in the last century, to investigate 
the health effects of air pollution on the large number of 
people who are now exposed.
For obvious reasons, most research was initially focused 
on the toxic effects of air pollution on the lungs, and it was 
shown that air pollution can exacerbate chronic lung diseases, 
including asthma, in adults and children.  However, in the 
early and middle 1990s researchers began to find, somewhat 
surprisingly, that air pollution also appeared to be associated 
with mortality from cardiovascular disease (CVD).  Two 
landmark studies in this area – the Six Cities Study and 
the American Cancer Society Study – that looked at large 
populations of people exposed to a wide range of levels of 
pollution strongly suggested that cardiovascular disease was 
associated especially with the particulate component (often 
referred to as “particulate matter” or “PM”) of air pollution 
(1,2).  Since those initial studies, many reports have confirmed 
a robust link between exposure to PM and cardiovascular 
disease and death, and more recent reports have also 
suggested a connection between ozone exposure and CVD. 
Publications in leading cardiovascular journals and other high 
impact journals, including a Scientific Statement on “Air 
Pollution and Cardiovascular Disease by the American Heart 
Association (3), suggest that the cardiovascular community 
is recognizing the potential contribution of environmental 
exposure to risk for CVD.
The significance of an air pollution–CVD connection 
could be quite profound.  While the associations that have 
been seen are fairly small, often less than 1% increase in risk 
per 10 microgram/cubic milliliter difference in PM levels, 
many people are exposed to air pollution, so the cumulative 
effect could be great.  In addition, cardiovascular disease 
(sometimes referred to simply as “heart disease”) is the 
primary cause of death in the industrialized world.  According 
to the American Heart Association, 927,448 people died of 
CVD in the United States in 2002.  This represents a death 
rate of 320.5 per 100,000 people and accounts for 38.0% of 
all deaths (4).  Depending on how significant a risk factor air 
pollution exposure proves to be, relative to the other known 
risk factors – age, race, lifestyle factors (such as smoking, 
physical inactivity, and diet), serum lipids, and family history 
– reduction in air pollution levels could be a means for 
significantly reducing the burden of CVD.
However, epidemiologic associations, although they may 
be strong, don’t completely make the case.  There is also the 
issue of “biological plausibility”:  does the association make 
sense based on what we know, or what we can learn, about 
the how cardiovascular diseases develop?  In other words, 
are there pathologic mechanisms to explain the association? 
This represents a major focus of research in the area of 
pollution-related CVD.
Several mechanisms to explain air pollution toxicity 
have been proposed and all have data to support them. 
These ideas developed mostly from research on the effects 
of PM.  The most obvious explanation is direct toxicity to 
the cardiovascular tissue.  This seems most plausible for 
chemicals that can be solubilized in the lung after inhalation, 
such as aldehydes and metals dissolved from particulate 
matter, and transported to the cardiovascular tissues, most 
likely through the blood.  However, there is also evidence 
that the particles can be translocated intact from the lung to 
vascular and cardiac tissues.  This is especially true for the 
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smaller, so-called, ultrafine particles.  Once in the vicinity of 
the CV tissue, the pollutants might adversely affect the tissue 
by causing or increasing local inflammation, interfering with 
metabolic processes, disrupting ion channel function, etc. 
The pollutants might also cause local inflammatory responses 
in the lung that result in production of inflammatory mediators 
that could be transported to the cardiovascular tissues, 
thus affecting function.  Either of these two mechanisms 
might explain experimental data showing an increase in 
atherosclerosis in animals exposed to PM (5).
A third hypothesis is that pollutants might trigger nerve 
endings in the lung which subsequently send impulses to the 
brain and in turn back to the heart.  These nerves are part of the 
autonomic nervous system and influence how the heart beats. 
This has been offered as a mechanism to explain evidence 
that PM in the lung can affect the rhythm of the heart.  It is 
of course likely that all of these mechanisms play a role.
There is one more important question that research 
needs to answer:  Why are individuals affected differently 
by exposure to air pollution?  What are the individual 
“susceptibility factors” that make one person more at risk 
from exposure to air pollution?  Evidence has begun to 
suggest that the elderly and those with pre-existing disease 
are most affected.  It is also reasonable to suspect that air 
pollution might worsen the effects of the “traditional” risk 
factors for CVD, such as smoking and diet.  And finally, an 
active area of research in all areas of disease susceptibility is 
the role of genetics.  A coordinated approach between basic 
laboratory science and population-based science is needed 
to fully resolve this question.
In the articles that follow, researchers from the University 
of Louisville, who are active this area of research, discuss 
many of the important considerations involved in trying to 
understand air pollution-related cardiovascular disease.  First, 
Drs. Prough, Amunom, and Conklin provide an overview 
of the chemistry of some chemicals in air pollution, such as 
polycyclic aromatic hydrocarbons and aldehydes.  In addition, 
they outline the metabolic processes the body uses to try to 
eliminate these exogenous chemicals, and importantly, how 
the processes sometime create metabolites that are more toxic 
than the original compound.  Finally, they discuss some of the 
consequences of the chemical reactions of these compounds 
with DNA and proteins.  In another chapter, Pierce and 
coworkers describe the use of mass spectrometry in defining 
protein adducts and their contribution to cardiotoxicology.
Drs. Hill, Barski, and Bhatnagar then review some 
of the epidemiologic findings linking air pollution and 
cardiovascular disease, as well as data linking occupational 
exposures to cardiovascular disease.  They also discuss work 
in their lab and in others’ that is looking at how exposure 
to aldehydes can cause alterations in serum lipid profiles, 
a known risk factor for cardiovascular disease in humans, 
and can reduce the body’s ability to protect the heart against 
ischemia, a common cause of heart attacks.  Dr. Prabhu’s 
overview focuses more on the effects of particulate matter, 
for which there is the most data related to cardiovascular 
disease.  In addition, he briefly discusses some of his 
research on aldehydes which shows that acrolein, a common 
aldehyde in various kinds of smoke including tobacco smoke, 
depresses the heart’s ability to function optimally, perhaps 
due to its effect on the protein that causes the heart muscle 
to contract.
Research on the health effects of air pollution continues to 
be an active and crucial scientific effort.  New epidemiologic 
data strengthen the case for a link between exposure and 
cardiovascular disease, as well as other conditions not 
previously considered, such as adverse birth outcomes.  As 
these data accumulate, the need to understand how these 
pollutants cause their effects becomes more important as well. 
Agencies such as the National Institute of Environmental 
Health Sciences (NIEHS) and EPA are currently funding 
research, such as that described here at the University of 
Louisville, to try to elucidate these mechanisms.  The results 
of this research cannot only lead to a reduction in the rate 
of disease from air pollution exposure through enactment 
of appropriate air pollution standards, but can also add to 
our overall understanding of the causes and the pathologic 
mechanisms of heart disease.
J. Patrick Mastin obtained he B.S. at Centre College, 
Danville, KY., and his Ph.D. degree in Pathology at Duke 
University. He took his first position with the NIEHS at 
Cincinnati and subsequently moved to Research Triangle 
Park, NC. where he is Chief of the Cellular, Organ and 
Systems Pathobiology section.
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Introduction
The concern that many products of combustion can cause 
adverse biological effects in mammals has stimulated research 
that provides a partial understanding of how compounds, like 
benzo[a]pyrene (B[a]P), cause specific cancers, such as small 
cell carcinoma. Like many other environmental chemicals, 
B[a]P, in and of itself, is not chemically reactive, but must 
be metabolically activated by enzymes in our cells. In the 
case of B[a]P, a polycyclic aromatic hydrocarbon [PAH], 
it has been well documented that it is formed during the 
combustion of tobacco or other organic materials and has the 
potential to cause cancer in animals and man. An elegant set 
of experiments performed in the 1970s (Holder et al., 1974; 
Selkirk et al., 1974; Kapitulnick et al., 1977; Levin et al., 
1986; Chang et al., 1987) documented that benzo[a]pyrene 
requires metabolism in mammalian tissues to form the 
ultimate carcinogenic agent. This reactive intermediate reacts 
with specific DNA bases in target genes to form DNA-PAH 
chemical adducts, thereby causing the critical somatic cell 
mutations that lead to cancer. Many of these studies were 
performed in animal models and a series of biological 
oxidative reactions studied in these models were shown 
to form the 9,10-epoxy-7,8-dihydrodiol-benzo[a]pyrene, 
the ultimate carcinogenic form of B[a]P (Holder et al., 
1974; Levin et al., 1986). The realization that such reactive 
intermediates are formed in our bodies with our own enzymes 
has been a paradox to understanding the carcinogenicity 
and/or toxicity of such compounds, since normally these 
enzyme systems detoxify foreign compounds by converting 
them to water-soluble, easily excreted metabolites. This 
article will review some of the compounds formed during 
the combustion process or inflammatory processes and how 
they are detoxified on the one hand and cause environmental 
disease on the other.
Compounds formed during the combustion process.
During the combustion processes associated with 
open fires, burning tobacco products, and automobile fuel 
combustion, organic materials are heated to extremely high 
temperatures and sometimes at high pressures in the presence 
of oxygen. Under conditions of complete combustion, i.e., 
in the presence of excess oxygen, most organic materials are 
converted to carbon dioxide and water, while compounds 
containing heteroatoms such as sulfur and nitrogen, are 
converted to ammonia, SO2, nitrogen oxides, etc. Such 
combustion reactions are known as complete combustion 
reactions and normally produce new chemical products with 
low chemical reactivity.
The energy associated with this process in the absence 
of excess oxygen causes pyrolysis reactions that lead 
to condensation reactions and formation of PAHs and 
decomposition reactions to small, reactive organic molecules, 
such as carbon monoxide (CO), acrolein and formaldehyde. 
This process is known as incomplete combustion and often 
forms chemicals with higher chemical reactivity. In addition, 
toxic metal oxides are produced from the metals in the 
organic material, such as arsenic used as wood preservatives, 
lead in older paints, etc. Due to the intense temperature and 
diverse conditions created during burning, both degradative 
oxidation to compounds like carbon dioxide and water are 
formed (expected during complete combustion). During 
The Role of Metabolism in Protection Against
Cardiotoxic Compounds
Russell A. Prough, Immaculate Amunom, and Daniel J. Conklin
Department of Biochemistry & Molecular Biology and the Division of Cardiology,
Department of Medicine, the University of Louisville School of Medicine, Louisville, KY.
Abstract
Combustion of organic matter in the presence of oxygen leads to complete combustion forming CO2, water, and oxides. 
Incomplete combustion leads for pyrolysis forming either fused ring molecules or unsaturated compounds, like acrolein and 
formaldehyde. The unsaturated compounds are chemically reactive and directly alter cell growth and differentiation. The 
fused ring compounds are chemically stable, unless metabolized by enzymes in our bodies to reactive intermediates. We have 
evolved several families of enzymes which detoxify these reactive intermediates. This article will review how products of 
pollution are formed, how they directly or indirectly react with biomolecules, and how they are toxic in the heart and other 
vascular tissues.
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incomplete combustion, unburned organics are formed 
including fused ring compounds, such as the polynuclear 
aromatic hydrocarbons, such as naphthalene, benzo[a]pyrene, 
and chrysene or carbon monoxide, aldehydes like acrolein 
and formaldehyde, sulfur dioxide, and nitrogen oxides 
produced (expected during incomplete or partial combustion). 
In the case of the smaller compounds, such as CO, sulfuric 
acid, hydrochloric acid, hydrofluoric acid, nitric acids and 
NO derivatives, these compounds can react with biological 
molecules, like hemoglobin, cytochromes, glycolytic enzymes, 
and alter their function; while the polynuclear hydrocarbons, 
dioxins, and furans may be largely chemically inert under 
these same conditions. Due to the diverse products formed 
from fire or other smoke producing processes, molecules are 
generated that either act directly to alter biological molecules 
or subsequently become metabolically activated to reactive 
intermediates by the enzymes in our body.
Electrophilicity and adduct formation: The chemical 
nature of toxic organic materials.
The foreign compounds formed by combustion processes 
can cause a number of responses. First, these compounds 
cause direct chemical or toxicological reactions of the 
electrophilic compounds formed during combustion. An 
electrophilic agent is one which is electron deficient, such as 
αβ unsaturated aldehydes (formaldehyde and acrolein), sulfur 
dioxide or nitrogen oxides. These compounds react with 
various cellular nucleophiles (electron-rich compounds), like 
glutathione [g-glutamyl-cysteinyl-glycine], a tripeptide thiol 
capable of reacting with reactive electrophilic compounds 
which like to gain electrons into their structure (Figure 
1). Thus, other biological nucleophiles, like proteins or 
nucleic acids, can also form such adducts with electrophilic 
compounds. The aldehydes described above are examples 
of reactive electrophiles formed during the combustion 
process that are directly reactive with biological materials 
like proteins and DNA or the cellular nucleophiles. 
These reactive chemicals are produced by the combustion 
process; however, new reactive intermediates may be 
formed biologically when enzymes in our bodies catalyze 
modification of various functional groups on other 
compounds formed during combustion. For example, 
combustion causes formation of PAHs during incomplete 
combustion of organic materials, including cigarette smoke. 
Examples of these compounds would include naphthalene 
and benzo[a]pyrene (Figure 2A). In and of themselves, these 
molecules are not chemically reactive, but upon metabolism 
by oxidative enzymes known as monooxygenases, these PAH 
can be converted into epoxides, compounds which are also 
electrophilic in nature (Figure 2B). Like the αβ unsaturated 
aldehydes, epoxides are capable of reacting with cellular 
nucleophiles, such as glutathione, proteins and nucleic acids 
of DNA (Figure 2C). So in summary, combustion produces 
compounds that are either direct acting chemicals, like αβ 
unsaturated aldehydes, or that require subsequent metabolic 
activation to produce reactive chemicals, like epoxides of 
polynuclear aromatic compounds.
The Body’s Defense: Mechanisms of foreign compound 
elimination.
Many of the organic compounds produced by combustion 
are fat-soluble and are taken up by our fatty tissues as a 
storage depot. This is one reason that exposure of mammals 
to foreign compounds is hazardous; i.e., their lipid-solubility 
causes the compounds to accumulate in the body and be 
stored for long periods of time. An example of this situation 
is the storage of polycyclic aromatic hydrocarbons and 
compounds like dioxin (formed both by forest fires and 
by man) in the fatty tissues of our bodies after exposure or 
ingestion of these materials. Without methods to remove these 
compounds from the environment so they won’t accumulate 
Figure 1. The reaction of the cellular nucleophile, glutathione or -glutamyl-
cysteinyl-glycine, with the combustion product acrolein (2-propenal) to form 
the GSH-acrolein conjugate.
Figure 2. The metabolism of polycyclic aromatic hydrocarbons. A. Naphthalene 
and benzo[a]pyrene. B. The oxidation of naphthalene to form naphthalene oxide. 
C. The reaction of glutathione with naphthalene oxide to form the glutathione 
conjugate of naphthalene.
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in the body, we have to rely on a series of enzymes that aid 
in the elimination of these compounds from the body. The 
difference in the rate of accumulation of these compounds 
in our fatty tissues and their elimination by metabolism to 
more polar compounds dictates how fast they leave our body. 
One way to describe the duration of retention of compounds 
in our body is the term half-life, or the time it takes for Ω of 
the body burden of a compound to be eliminated through the 
kidneys or gastrointestinal (GI) tract. 
Using a battery of enzymes that are oxidative, reductive 
and/or conjugative (i.e., linking a water-soluble compound 
to a fat-soluble compound) in reaction type, our organs, 
especially the liver, can metabolize both direct and indirect 
acting reactive chemicals by attaching an oxygenated 
functional group to the molecule. Subsequently, other 
enzymes add a water-soluble compound like a sugar, sulfate, 
water, or glutathione to the molecules. In the pharmacology 
literature, the oxidative/reductive enzymes have been termed 
Phase I metabolic enzymes; the conjugative enzymes are 
therefore termed Phase II synthetic enzymes. Finally, 
there are processes that extrude these compounds or their 
metabolites from the tissues into the blood stream, urinary 
tract, or GI tract for disposition from the body; this process 
is called transporter enzymes or Phase III enzymes. For most 
chemicals, these reactions produce compounds which are 
not toxic and by adding water-soluble molecules to these 
oxygenated molecules, are made more water soluble. This 
increased solubility allows these water-soluble materials to 
be removed from fatty tissues and organelles in our liver 
and other tissues and export them to the kidney or feces 
for elimination. If the compounds formed have little or no 
toxicity, then the compounds are rapidly and efficiently 
removed from our body. These processes decrease the half-
life of organic molecules in our body through enhanced 
disposition after metabolism. Our livers are designed to be 
very active in eliminating such compounds from the body 
and serve as a “garbage system” for elimination of fat-soluble 
compounds, both foreign compounds and endogenous 
compounds, including cholesterol and fat.
The enzyme systems of importance that are involved in 
eliminating such compounds are listed in Table 1 above. The 
major oxidative enzyme encompasses a heme-thiolate protein 
family containing over 100 distinct genes in mammals. It 
carries out oxidation of carbon compounds by attaching an 
oxygenated functional group that eventually can become linked 
to water-soluble biomolecules, increasing the water solubility 
of these combustion products. The sorts of water-soluble 
molecules that are involved in conjugation reactions include 
glutathione (-glutamyl-cysteinyl-glycine or GSH utilizing 
glutathione S-transferases), glucuronic acid (UDP-glucuronic 
acid utilizing UDP-glycosyltransferases), sulfate (3’-
phosphoadenosine 5’-phosphate utilizing sulfotransferase), 
acetate (acetyl-CoA utilizing N-acetyltransferases), and water 
(H2O utilizing epoxide hydratase).
Many of the metabolic processes in mammalian cells 
have the ability to alter the expression of various genes 
to compensate for times when more or less metabolism is 
needed. These same processes exist in toxicology, since it 
has been shown that an organism is highly sensitive to a 
chemically-reactive material upon first exposure, but during 
subsequent exposure to the compound less toxicity results. 
This process is known as “tolerance” and can be explained 
by a number of biological mechanisms. One part of this 
process is known as “induction” and generally is due to an 
increase in transcriptional activity of gene expression and 
the accumulation of the protein catalysts in our tissues and 
cells. This inductive process allows compounds to which 
we are exposed to have the ability to increase their own 
metabolism; through activating specific receptors in target 
tissues like liver, these receptors function after chemical 
exposure, like the sex steroids act through nuclear receptors 
or transcription factors (Nebert et al., 2004; Whitlock et 
al., 1997). One particular receptor is the Arylhydrocarbon 
receptor (AHR) which is ubiquitously distributed throughout 
the body (Figure 3). The PAHs formed during incomplete 
combustion activate this receptor in those tissues that become 
exposed to these materials. Upon entry into the cell and 
binding to the AHR, the compounds cause the AHR to migrate 
TABLE 1. Common enzymes involved in foreign compound metabolism
 Enzyme Reaction type Reactant Cofactor
 Cytochrome P450 HydroxylaseEpoxidase Molecular oxygen Reduced pyridine nucleotides
 Glutathone S-transferase Thiol conjugation Electrophile Glutathione
 Sulfotransferase Sulfate conjugation Phenol 3’-Phosphoadenosine 5’-phosphate
 Glycosyltransferase Glucuronidation Phenol UDP-glucuronic acid
 N-acetyltransferase Acetylation Amines Acetyl-Coenzyme A
 Epoxide hydratase Hydration Epoxides Water
Fall/Winter 2006
to the nucleus of these target cells and activate a battery 
of genes involved in disposition of combustion products 
and other chemicals, eventually resulting in the increased 
expression of the messenger RNA and protein encoding the 
enzymes involved in foreign compound metabolism, such 
as cytochrome P4501A1, UDP-glucuronosyltransferase, etc. 
The enhanced excretion of the foreign compounds results 
from this increased expression of the genes involved in 
disposition of foreign compounds and enhances elimination 
of these compounds from the body. These receptors often 
also increase other biomolecules serving as protective 
agents for the body, like glutathione. The oxidative enzymes 
also catalyze a limited number of reactions leading to 
deleterious reactions, such as DNA and protein activation. 
The paradoxical dichotomy of these enzymes’ action in 
activating a limited number of chemicals and their major role 
in eliminating most other chemicals, including those we take 
as drugs and beneficial compounds, causes us to be cognizant 
of the importance of limiting our exposure to combustion 
compounds and other materials that may be bioreactive or 
can be made bioreactive.
Many other ligand-activated nuclear receptors or 
transcription factors exist which can interact with foreign 
compounds as well as endogenous compounds. Another 
important receptor is the NF-E2-related (Rushmore et al., 
1990; McMahon et al., 2991; McMahon et al., 2003) nuclear 
transcription factor (also known as Nrf2) which is released 
from a cytoplasmic protein complex upon binding of 
electrophilic compounds. The subsequent accumulation of 
Nrf2 in the nucleus activates another discrete set of target 
genes important for increasing the concentration of other 
enzymes, including GSH synthase, heme oxygenase, and 
many other protective enzymes. This regulatory system is 
involved in protecting against the direct acting chemicals 
formed like NOx, αβunsaturated aldehydes, sulfur dioxide, 
metals; i.e, the compounds also produced by the incomplete 
combustion process.
Reactive chemicals cause abnormal cell growth and 
proliferation.
In the past, considerable research has been directed 
toward understanding how toxic chemicals cause cancer. 
The consensus is that foreign compounds are converted 
to reactive electrophiles that can chemically react with 
cellular nucleophiles like protein and nucleic acid to form 
products known as adducts. Such reactions are believed to 
lead to toxicity by damaging proteins by forming protein 
adducts or carcinogenesis by forming DNA adducts that 
result in somatic cell mutations and cancer. However, the 
literature offers a second role for toxic chemicals in causing 
abnormal cell proliferation and inflammation that results in 
formation of aberrant tissue growth and development, such 
as atherosclerosis. Chemicals such as the a,b-unsaturated 
aldehydes or reactive electrophilic intermediates of polycyclic 
aromatic hydrocarbons may be part of this second mechanism 
for causing disease in humans (Bhatnagar and Srivastava, 
1992; Ramos et al., 1996; Moorthy et al., 2002). Aberrant 
proliferation of vascular smooth muscle cells has long been 
known to allow these cells to calcify and form plaque in 
arteries and aorta. This aberrant cell growth, accumulation of 
lipid and calcification eventually results in closure of vessels 
leading to and throughout the heart, causing cardiovascular 
disease and atherosclerosis. Therefore, these exposures to 
reactive chemical intermediates can not only cause cancer, 
but also other chronic diseases like atherosclerosis, heart 
disease and possibly other diseases like diabetes. This is 
schematized in Figure 4 showing that aldehydes, R-CH=O, 
like formaldehyde or acrolein formed by decomposition 
of volatile organic compounds cause toxic endpoints 
such as atherosclerosis, dyslipidemia (excess lipid in the 
bloodstream), and endothelium dysfunction (inadequate 
endothelial cell function). These lead to diseases like diabetes, 
obesity, hypertension, etc.
The research being pursued at the University of 
Louisville in our laboratories focuses on how these disease 
Figure 3. The arylhydrocarbon receptor and its action. Polycyclic aromatic 
hydrocarbons can passively diffuse into cells and interact with the Arylhydrocarbon 
receptor (AHR) in the cytoplasm. Activation of the protein complex associated with the 
AHR causes a migration to the nucleus where it combines with the arylhydrocarbon 
receptor nuclear transporter (ARNT) and bind to cognate responsive elements on 
the 5-flanking region of genes. This leads to the production of mRNA’s capable of 
encoding enzymes which detoxify compounds like benzo[a]pyrene to hydroxylated 
metabolites that are not toxic. These metabolites must also be easily excreted from 
the body to diminish environmental disease.
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states arise and how they can be prevented. Our particular 
interest is to see how oxidative and reductive metabolism 
may blunt these toxic events, protecting against aberrant 
cell proliferation. A number of enzymes are involved in 
these oxidation-reduction processes (Figure 4 and Table 2). 
Aldose reductase (AR) or the aldo-ketoreductase (AKR) 
enzyme families chemically reduce aldehydes to alcohols, 
that tend to be less toxic than the aldehyde compounds. In 
addition, aldehyde dehydrogenases use NAD(P)+ to oxidize 
aldehydes to carboxylic acids. Both the alcohols and and 
carboxylic acids can be conjugated with water-soluble 
compounds that enhance excretion through the kidney or 
into the bile. Recently, we have noted that the hemoprotein 
family, cytochrome P450 (also know as CYPP450), can 
also oxidize and reduce aldehydes to carboxylic acids and 
alcohols as well (Amunom et al., 2005). This enzyme system 
has high capacity to remove these foreign compounds and 
appears to serve as a secondary system to protect the body 
from aldehydes when the capacity of the reductases has been 
attained.
Societal problems due to our reliance on modern 
chemical and electrical conveniences.
As seen in the cover of this issue of Sustain, a paradox 
exists in our modern life-style. The freeway shown with 
vehicles moving rapidly through the hospital curve at 
Louisville is a great benefit to our freedom to travel and 
transport goods around our city at will. The electricity 
produced by coal-fired power plants or products like hot water, 
etc. to which we have become accustomed all require the use 
of combustion of petrochemicals to maintain our lifestyles. 
From the 1950s to the 1980s, we slowly realized that the 
pollution formed from release of combustion processes like 
the automobile engine or coal-fired power plants or chemicals 
from our chemical plants pose a threat to our health through 
a number of malignancies. With the advances in industrial 
technology, workers are increasingly protected from direct 
industrial exposure to such chemicals produced in West 
Louisville. However, the wonderful freeway systems and 
coal-fired power plants continue to expose us to pollution that 
appears to lead to deleterious diseases like atherosclerosis, 
dyslipidemia, and perhaps even diseases like diabetes. The 
coming decade will hopefully provide us with information 
about how the environmental pollution we produce in our 
modern lifestyle causes these emerging diseases threatening 
our populace. In some part, the knowledge we gain about 
how these processes work may allow us to prevent or treat 
these diseases and increase the quality and quantity of life 
for the Citizens of Louisville. However, this realization also 
forces us to devise ways to decrease further the chemical and 
particulate pollution we generate. Since all of these pollution 
products affect health and cause environmental disease, the 
other chapters in this issue will further document the role of 
such chemicals in emerging environmental diseases.
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Figure 4. The role of metabolism in detoxification of aldehydes formed from 
volatile organic compounds that lead to aberrant cell proliferation. AR, Aldose 
reductase; AKR, aldo-ketoreductases; ALDH, aldehyde dehydrogenase; CYP, 
cytochrome P450; VOC, volatile organic chemicals; R-CH=O, chemical formula 
for an aldehyde.
Table 2. Enzyme systems involved in oxidative-reductive metabolism of aldehydes formed from volatile organic compounds
 Enzyme Reaction Coenzyme Reaction type
 Aldose reductase Glucose ‡ Sorbital NADPH Reduction
 Aldo-keto reductase Aldehyde ‡ Alcohol NAD(P)H Reduction
  Ketone ‡ alcohol
 Aldehyde dehydrogenase Aldehyde ‡ carboxylic acid NAD(P)+ Oxidation
 Cytochrome P450 Aldehyde ‡ carboxylic acid NADPH + O2 Oxidation
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Figure 1. Classification of particulate matter. Adapted from Brook et al./ AHA Scientific Statement # 71-0289, 
URL: http://circ.ahajournals.org/cgi/content/full/109/21/2655/FIG1.
Several pollutants are present in ambient air, and include 
particulate matter (PM) and gases. PM is a complex, dynamic 
mix of solid and liquid particles suspended in air. A large 
array of chemicals has been identified in PM. Some of the 
more common PM components include: 1) elemental and 
organic carbon, nitrates, and sulfates; 2) organic compounds 
such as aldehydes and polyaromatic hydrocarbons; 3) metals 
and metal oxides; and 4) biological compounds including 
bacterial products and pollen grains. Gaseous components 
include nitrogen oxides, sulfur dioxides, carbon monoxide, 
and ozone. PM is classified based on particle size; generally, 
an aerodynamic diameter < 10 microns (termed thoracic 
particles or PM10) can penetrate and deposit in the lungs 
and are considered the most deleterious to health (Figure 
1). According to current convention, PM10-2.5 particles are 
referred to as the coarse fraction, PM2.5 and less as fine 
particles, and PM0.1 and less as ultrafine particles. Ultrafine 
particles have the potential for increased toxicity and may 
even pass directly into the bloodstream from the lungs.
 Pollutants arise from both man-made and natural 
sources. Human-derived sources include industrial and fossil 
fuel combustion, motor vehicle emissions, and environmental 
tobacco smoke and are generally PM2.5. Natural sources 
include windblown soil, forest fires, and bioaerosols and are 
generally PM10-2.5. Ozone, a principal constituent of urban 
smog, is formed via the effects of ultraviolet radiation from 
the sun on both oxygen in the atmosphere and nitrogen 
oxides and hydrocarbons derived from human activity. It 
is important to recognize that PM composition is variable 
over time and location, and that the adverse health effects 
may be secondary to any one of the thousands of chemicals 
that have been detected in PM. Indeed, determining the 
precise effects referable to each constituent can be quite 
difficult. Furthermore, although PM refers specifically to 
air pollutants, many of its chemical constituents are also 
found in other environmental sources. One such example 
is a group of environmental pollutants termed aldehydes, 
which comprise an area of active research interest at the 
University of Louisville. While aldehydes are important 
volatile components of PM2.5 and tobacco smoke, they are 
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ubiquitous and are also present in water and food. Thus, the 
potential health effects of specific pollutants theoretically 
should consider exposure derived from all environmental 
sources.
 The World Health Organization considers air pollution 
as one of the top 10 causes of disability that accounts for 
nearly 700,000 deaths annually. It is projected that if the 
current pattern of fossil-fuel consumption and emissions 
continues there will be nearly 8 million air pollution-related, 
and potentially avoidable, deaths by the year 2020. From a 
public health standpoint, while air pollution has classically 
been recognized as an exacerbating factor for lung diseases 
such as asthma and for the development of certain cancers, 
the epidemiological link between environmental pollution 
and heart disease has only been assiduously described in 
the last several years, and thus the concept of pollution as a 
risk factor for heart attacks, heart failure, and abnormal heart 
rhythms has been slower to gain acceptance.
 Several population-based studies have demonstrated 
an important and potentially causative association between 
both short-term and long-term human exposure to PM and 
cardiovascular illness. These investigations have strong 
implications for the formulation of regulatory policies 
regarding acceptable levels of pollutants from human 
activity such as industrial and automobile emissions. Short-
term studies have evaluated the relationship between recent 
pollution exposure and adverse outcomes. Although these are 
often analyses of heart disease in relation to the day-to-day 
variation in air pollution (generally 1-2 day lag period), the 
effects have been noted to persist when evaluated at longer 
periods after exposure (e.g., > 40 days). The initial impetus 
for such research was provided by the observation of higher 
mortality rates during extreme elevations in air pollution. 
During the London fog incident of December, 1952, for 
example, there was a precipitous increase in air pollution 
due to stagnant weather. Review of available hospital records 
from that time suggested an excess of 12,000 additional 
deaths over several months after the event due to both cardiac 
and respiratory causes. 
 More recent epidemiological studies conducted in the 
United States (National Mortality and Morbidity Air Pollution 
Study [NMMAPS]) and Europe (Air Pollution and Health: 
a European Approach [APHEA-2]) have shown remarkably 
consistent associations between deaths due to heart and lung 
diseases (i.e., cardiopulmonary mortality) and PM levels the 
day before death. The overall increase in risk (~0.2-0.5% for 
each increase in PM10 exposure of 10 micrograms/meter
3) 
is quite small compared to traditional risk factors for heart 
disease such as cholesterol levels, high blood pressure, 
diabetes, obesity, and cigarette smoking. However, since 
air pollution exposure is ever-present, the absolute number 
of people affected can be very large. For example, in one 
analysis of the effects of PM exposure in the Netherlands, a 
small European country, this 0.5% increase in risk translated 
into an excess of at least 2100 deaths per year, twice the 
number there due to traffic accidents. Direct associations 
have been demonstrated between PM and chest pain and heart 
attacks, heart failure and difficulty breathing, abnormal heart 
rhythms and shocks delivered from implanted defibrillators, 
and stroke. Recent studies have also indicated a relationship 
between spending time in traffic and the risk of a heart attack 
an hour afterward, and the level of ozone exposure and the 
number of heart attacks within a period of 1 to 2 days.
 Of equal significance, studies of long-term exposure to 
PM have also demonstrated increased all-cause mortality, at a 
level of 4% for every 10 micrograms/meter3 in annual PM2.5. 
These investigations included the Harvard Six Cities Study 
results published in 1993 and the American Cancer Society 
Cancer Prevention Study published in 2004. Importantly, 
cardiovascular deaths, and not respiratory illnesses, were the 
single largest category of increased mortality due to chronic 
PM exposure, and were linked to ischemic heart disease (i.e., 
heart attacks and angina), abnormal heart rhythms, heart 
failure, and cardiac arrest. Studies on secondhand smoke 
(SHS), the largest contributor to indoor PM, underscore the 
chronic effects of PM exposure on cardiovascular health. 
Nonsmoking spouses of smokers have an estimated 25% 
increase risk of heart disease, and an estimated 2-fold increase 
risk of stroke. A more vivid example of the impact of SHS 
on heart disease was seen in June, 2002, when a public 
The Jewish Hospital 
Heart
and Lung Center 
located in the medical 
complex
in downtown Louisville, 
KY.
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smoking ban was instituted in Helena, Montana. In the first 
6 months of the ban, hospital admissions for heart attacks 
dropped by 40%; this effect was not seen in hospitals from 
surrounding towns. The totality of evidence thus implies a 
causative link between ambient PM exposures and both acute 
and chronic cardiac illness. Additionally, several groups of 
individuals appear to be particularly vulnerable to these 
effects. These include the elderly, those with pre-existing 
heart and/or lung disease, those with diabetes, and those of 
lower socioeconomic status. Active tobacco smoking also 
increases the individual’s susceptibility to heart failure, 
abnormal heart rhythms, and cardiac arrest due to pollution 
exposure.
 Although the epidemiological evidence linking PM 
exposure and heart disease morbidity and mortality is 
strong, much less is known as to precisely how PM exposure 
engenders these effects. It is thought that fine air particles 
may impact our heart and blood vessels in several ways. 
They may have direct effects on the heart and arteries, as 
particulates such as ultrafine particles, bacterial products, 
and metals readily pass from the lungs after inhalation into 
the bloodstream. Fine particles can also initiate generalized 
inflammation in the body that can serve to constrict blood 
vessels and promote the formation of blood clots, and 
aggravate the progression of fat deposits in arteries. The 
right combination of abnormalities in susceptible persons can 
compromise blood flow in the arteries that supply the heart 
or brain, resulting in a heart attack or stroke. In this regard, it 
has been shown that short-term exposure to environmentally-
relevant concentrations of a mix of PM2.5 and ozone provokes 
arterial constriction and narrowing even in healthy adults.
 PM inhalation can also alter the heart rhythm. Normally, 
the heart rate has a given degree of variability due to cyclic 
fluctuations in the output of the autonomic nerves to the heart 
that regulate the heartbeat. Exposure to ambient PM reduces 
this variability, perhaps related to the activation of neural 
reflexes in the lung in response to injury or inflammation, and 
the suppression of the normal output of the autonomic nerves. 
While in healthy individuals these effects may go unnoticed, 
in patients susceptible to heart arrhythmias significant 
abnormalities in the heart rhythm, and perhaps even cardiac 
arrest, can occur. This effect is particularly important in 
patients with heart failure, as such patients already have 
underlying abnormalities in the normal variability of the 
heart rate and heightened susceptibility to abnormal heart 
rhythms. Indeed, although death due to heart failure makes up 
about 10% of all cardiovascular deaths overall, heart failure 
deaths account for 30% of cardiovascular deaths related to 
PM exposure.
 The development of strategies to reduce the cardiac 
health risk from pollution exposure requires public health and 
regulatory initiatives, as well as a scientific understanding 
of the underlying mechanisms responsible for these effects. 
From a population standpoint, more stringent regulation 
of environmental pollution is the most effective method to 
reduce adverse health effects associated with PM. This will 
require intense effort and collaboration between several 
groups including the public via their elected local, state and 
federal legislators, industry, and the scientific community. 
There also needs to be awareness of the potentially large 
costs involved for air pollution abatement, and consensus 
agreement as to what constitutes “acceptable” levels of 
exposure. However, discovering the underlying mechanisms 
is as important, especially for susceptible patient groups. 
What may be a tolerable level of exposure for healthy 
persons may produce adverse consequences in vulnerable 
individuals. At the University of Louisville School of 
Medicine, several researchers have been interested in 
determining the specific biological mechanisms that account 
for the association between environmental pollution and heart 
disease. As discussed above, the chemical makeup of PM is 
quite complex and a large knowledge gap exists regarding 
the specific health effects referable to select chemical 
constituents of PM. Due to several lines of epidemiological 
and experimental evidence, we have been particularly 
interested in a group of pollutants called reactive aldehydes. 
Our research group wants to determine how these pollutants 
affect the structure and function of the heart and the heart’s 
ability to withstand reductions in blood flow, and how 
pre-existing heart disease (due to heart attack) changes the 
response to these pollutants.
We have an interest in aldehydes for several reasons. 
First, aldehydes are ubiquitous pollutants. They are generated 
during the combustion of fossils fuels, and are abundant in 
automobile exhaust, cigarette smoke, natural and man-made 
fires, and industrial waste, and are an important component 
of PM. Specific aldehydes such as acrolein have also been 
designated by the Environmental Protection Agency (EPA) as 
high priority pollutants in drinking water, and others such as 
hexenal are present in cooked foods and fats. Second, specific 
aldehydes (acrolein is one example) can be particularly toxic 
to biological systems. In the words of the EPA, “acrolein 
is estimated to pose the highest potential on a nationwide 
basis for significant chronic non-cancer effects.” Third, 
exclusive of environmental exposure, all of us also generate 
small amounts of these reactive aldehydes in our own body 
during the course of normal metabolism – this balance can 
be radically altered in diseases such as heart failure. Such 
changes within the body may provide clues as to why certain 
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groups of individuals are more susceptible to environmental 
exposures of similar chemicals. Lastly, although several 
experimental and epidemiologic studies hint that aldehydes 
(derived either externally from the environment or internally 
within the body) contribute to heart dysfunction and cardiac 
disease, this relationship has not been systematically or 
critically examined and is poorly understood. Therefore, it is 
our intent to evaluate the consequences of aldehyde exposure 
on the heart and to probe the specific mechanisms by which 
this occurs. 
Thus far, we have discovered several new and important 
effects of aldehydes on the heart. We have seen that 
acute exposure to acrolein, a model reactive aldehyde, 
can profoundly depress heart function and also increase 
the sensitivity of the heart to reductions in blood flow, or 
ischemia. These effects are reversible and may be related 
to selective effects of acrolein on the contractile proteins 
and energy-generating systems of the heart. These types of 
effects may be important during acute and/or occupational 
types of exposures and suggest that such aldehyde-induced 
effects can contribute to the reported increase in heart attacks 
and dysfunction upon short-term pollution exposure. Just 
as important, we have also determined that chronic oral 
exposure to acrolein induces inflammation in the heart 
resulting in the appearance of dilated and dysfunctional 
heart tissue suggesting incipient heart failure. These findings 
raise the intriguing possibility that environmental pollutants 
may contribute to the development of cardiomyopathy 
of otherwise undetermined origin. All of these studies 
underscore the potential interactions between pollutants 
(specifically aldehydes), heart dysfunction, and heart disease, 
and constitute the first experimental evidence suggesting 
that environmental aldehydes could trigger or affect clinical 
cardiac disease. In the next few years, we plan to do further 
experiments to expand on these early results, and develop 
a working model for how aldehyde pollutants contribute to 
and/or induce heart pathology. 
In summary, the accumulating evidence supports 
the notion that environmental pollution is a novel and 
infrequently recognized risk factor for a variety of cardiac 
diseases including heart attacks, heart failure, abnormal 
heart rhythms, and sudden cardiac death. The mechanisms 
may be related to direct effects, indirect effects due to the 
induction of inflammation, and altered regulation of the heart 
rhythm. The importance of specific pollutants in producing 
adverse health effects is under active investigation; our 
work suggests an important role for reactive aldehydes in 
producing heart dysfunction, increased susceptibility to heart 
ischemia, and heart failure. A focused effort on the part of the 
public sector, industry, and researchers will be required to 
institute appropriate regulatory initiatives, and to combat the 
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Health effects of pollution are a growing concern 
worldwide.  Ever since the industrial revolution, we have 
altered the environment in significant ways such that the 
results of our activities have proven to be harmful to wildlife, 
delicately balanced ecosystems, and our own health. We now 
clearly know that polluted air and water do not only affect 
rain forests and grasslands but also the risk, incidence, and 
severity of some of the most serious of human diseases. 
The extent of the problem or the degree to which pollution 
contributes to the overall burden of human disease is not 
known.  It has been estimated that in 1997 alone there were 
700,000 worldwide cases of avoidable deaths due to indoor 
and outdoor air pollution.  These deaths have been linked 
to suspended particulate matter, largely from outdoor urban 
exposures. This does not include deaths due to other sources 
of pollution such as contaminated food or water.  What is 
even more alarming is that the World Health Organization 
(WHO) estimates that by the year 2020 there will be eight 
million deaths related to air pollution alone (1).  The situation 
is particularly grim in developing countries such as India 
where deaths due to pollution exceed those due to cancer 
and heart disease combined.  The conditions in the developed 
world are not much better.  Early work by environmentalists 
and concerned legislators has dramatically reduced the levels 
of several pollutants (lead, mercury, second-hand cigarette 
smoke), however, several toxic chemicals continue to pollute 
our environment and their harmful effects are only now 
coming to light. The most significant of these pollutants are 
the air-borne particulates.  These are small invisible particles 
that are present in the air and are generated from human 
activity.  Coarse particles are created by actions such as the 
grinding and grating of surfaces and the rubbing of tires on 
the surface of roads, whereas the finer ones emanate from 
automobile emissions and power plants (2;3).
A pivotal study linking air particulates to adverse health 
outcomes was published by a group of investigators from 
Harvard in which they showed that people living in cites 
with high levels of particulates had lower life expectancy 
than people living in more polluted urban areas that had 
subordinate levels of particulates.  Their comparison was 
based on data collected from six cities across the United 
States and it showed that if you lived in Stubenville, Ohio 
you could expect to die earlier than if you lived in Topeka, 
Kansas (4).  While the overall conclusion that pollution 
affects life expectancy was not a big surprise, the startling 
finding was the link between particulates and health 
outcomes.  These particles are present in the air everywhere 
and are particularly high in urban areas.  Does this mean that 
everyone is at risk, and, if so, to what extent and how does 
particulate air pollution contribute to chronic disease?  The 
answers have been slow in coming and even after fifteen 
years of research and hundreds of published studies we have 
only marginally addressed these concerns. We know that 
particulate air pollution increases the incidence of cancer. 
Moreover, it can exacerbate asthma, and people with chronic 
lung disease are more susceptible to the harmful effects of 
air pollution.  However, research since the famous six-city 
study has yielded another surprise.  In analysis of the cause 
of deaths that could be linked to air pollution, it was found 
that most of the excessive deaths attributed to particulate air 
pollution were due to heart disease (5). 
The reason that the link between heart disease and 
air pollution was surprising was that little was known 
about how environmental pollutants affect heart disease. 
Although there were a few studies linking heart disease 
and exposure to solvents, cardiovascular toxicity was not 
usually measured as an outcome of pollutant exposure, even 
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new risk factor for cardiovascular disease?
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Pollution from the combustion of fossil fuels has emerged as a major contributor to environmental deterioration and 
human disease.  Evidence accumulated over the last ten years supports an explicit link between heart disease and pollutant 
exposure, and it is currently believed that the majority of deaths due to air pollution are due to cardiopulmonary diseases. 
Thus, an understanding of how the constituents of pollutants in air, water, and cigarette smoke affect the cardiovascular system 
is of primary importance.  Accordingly, rigorous studies within our laboratories are shedding new light on the mechanisms 
by which specific components of pollution contribute to heart disease.  
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in controlled laboratory conditions. 
The reasons for such omission 
are not clear but could relate to 
the tacit assumption that the heart 
and blood vessels were somehow 
protected from the environment. 
Overall, the emphasis was and is on 
cancer and lung disease because of 
the consequences pragmatic to air 
pollution.  Thus, there seemed no 
reason to suspect that heart disease 
could be negatively affected by 
pollution.  However decades of 
research on cigarette smoke, which 
is the most frequent toxic pollutant 
to which humans are exposed, 
indicate that quite the reverse may 
be true.   
The unhealthy effects of 
cigarette smoke have been under 
scrutiny since the early 1950’s, 
and we are only now beginning 
to recognize the complexity of 
mechanisms by which smoking 
contributes to several diseases. 
Nearly all of the initial studies 
focused on the relationship between 
cancer and smoking.   However, 
several studies clearly show that 
smoking significantly affects heart 
disease, and heart disease deaths 
due to tobacco use far exceed 
the number of deaths due to 
lung cancer.  In recent estimates, 
smoking kills five to six times 
more people by increasing heart 
disease than causing lung cancer 
(6).  Fortunately, technology is now 
allowing researchers to identify 
thousands of compounds contained 
within cigarette smoke, and these 
investigations have already played a 
role in the realization that voluntary 
inhalation of cigarette smoke is 
detrimental to the cardiovascular 
system.  More importantly, recent 
studies are revealing that sidestream 
(second-hand) smoke is drastically 
more toxic than mainstream smoke. 
Analyses in these investigations 
Fig. 2: Risk of premature death from PM2.5 particles in ambient air (from Science 307, 1858-1861, 2005).
Fig. 1:  Model PM10 distribution in the United States
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demonstrated that sidestream smoke is approximately four 
times more toxic per gram than mainstream smoke, leading to 
the conclusion that “smoke-free public places and workplaces 
are the only practical way to protect the public from the 
toxins in sidestream smoke.” Other studies have shown a 
direct link between second-hand smoke and cardiovascular 
disease, underscoring the evidence of smoking as the leading 
cause of preventable death (7).  While this has been known 
for many years, it is only now that the full impact of these 
data is coming into view.  The lessons learned from the 
health effects of smoking may be particularly useful as we 
begin to probe how other air pollutants affect heart disease. 
Cigarette smoke contains several pollutants present in 
ambient air (e.g., particulate matter, butadiene and aldehydes) 
that have been independently linked to heart disease (vide 
infra), suggesting that their presence could precipitate 
cardiovascular infirmities.
Overwhelming evidence accumulated over the last ten 
years supports the link between heart disease and air pollution 
(2;5;6).  Over a hundred epidemiological studies have been 
published showing that deaths due to heart disease increase 
on days of high pollution. It has been shown that a sharp spike 
in air borne particles is followed one to three or twenty-four 
hours later by an increase in heart attacks. This relationship 
has been found in many cities as different from each other 
as Boston from London or New York from Los Angeles. 
Further analysis of the cause of mortality showed that most 
of the deaths were due to acute myocardial infarction (heart 
attack), however deaths due to arrhythmias and heart failure 
were also increased.  The EPA estimates that of the 350,000 
yearly cases of sudden cardiac deaths in the United States, 
60,000 could be related to particulate air pollution (8). In 
general, it is currently believed that 70 to 80% of excessive 
deaths due to air pollution could be due to cardiopulmonary 
causes (9).
Therefore, if we accept the data that air pollutants and 
smoking increase the incidence of heart disease, then we are 
left with the question why?  Again, no one knows for sure. 
Despite extensive epidemiological data published over three 
decades, it is still not known how smoking increases the 
incidence of heart disease. With particulate air pollution, the 
problem may be even more difficult to solve. The particles 
themselves vary greatly in size and composition and there is 
little agreement between the experts as to which components 
of the particles are causing the health effects.  Thus, either 
the particles themselves or some other pollutant (e.g., 
sulfates, ozone, or nitrous oxides) that increases in parallel 
with particulate pollution could be causing the excessive 
mortality.
To simplify the problem and to study it rigorously within 
a laboratory setting, we have begun a series of studies on 
the aldehydic components of urban air and particulates. 
Aldehydes are reactive chemicals that are pervasive in our 
environment (10).   They are present in food – the crisp smell 
of fresh fruit or spices is due to aromatic aldehydes such as 
citral (in citrus fruit) and cinnamaldehyde (in cinnamon) 
(Table 1-page 20).  They are also responsible for the aroma 
of cooked food and the putrid smell of rancid meat (11). 
Aldehydes are also present in all types of smoke as they are 
inevitably generated by combustion (Table 2 and 3-page 
21). One of the most common of these is acrolein – which 
is responsible for the acrid smell of smoke. Many aldehydes 
are also present in urban drinking water supply streams, as 
well as in streams, rain or fog.  The EPA estimates 
that, with the exception of metals, aldehydes are 
the most prevalent pollutants in drinking water that 
represent the highest health threat.  
Not all aldehydes are bad, and several aldehydes 
such as those present in herbs, spices, and fruits have 
anti-inflammatory properties.   Moreover, most of 
the aldehydes ingested are efficiently removed by the 
body by a variety of enzymes systems (e.g., aldehyde 
reductase, aldehyde dehydrogenases, alcohol 
dehydrogenases and glutathione-S-transferases) 
that have evolved specifically to detoxify foreign 
aldehydes. Thus, moderate aldehyde consumption 
or exposure does not elicit any untoward effects. 
However, persistent exposure to low levels of 
environmental aldehydes such as those generated in 
deep-fried food or cigarette smoke or those produced 
Figure 3
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Table 1:  Aldehydes identified in foods
TABLE 1
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in the atmosphere from automobile exhaust and industrial 
emissions could be particularly harmful.  
For now, it is not known for certain whether aldehydes 
in the atmosphere negatively impact human health and 
what those affects are.  However, there are tell-tale signs or 
suggestions that exposure to aldehydes could be harmful, 
particularly to cardiovascular health.  Many studies have 
shown that occupational exposure to aldehydes could 
increase the risk for cardiovascular disease.  These studies, 
reporting an increased risk of atherosclerotic heart disease in 
embalmers (12), undertakers (13), perfumery workers (14), 
bus drivers (15), or workers in formaldehyde-producing 
plants (16), support the view that exposure to aldehyde-rich 
environments could be deleterious to cardiovascular health. 
Indeed, the recent push to ban smoking in public places 
such as restaurants and bars results from the realization that 
second-hand smoke is capable of precipitating acute cardiac 
events and may also negatively influence the chronic process 
of atherogenesis.
Exposure to industrial chemicals such 
as butadiene and vinyl chloride has also 
been linked to heart disease.  In an extensive 
study of workers in styrene-butadiene rubber 
polymer manufacturing plants from 1943-
1982, it was found that African-American 
workers were at a two-fold higher risk of 
developing heart disease than those who 
did not work at the plant (17).  Interestingly, 
exposure to butadiene did not increase the 
risk for heart disease in Caucasian workers. 
These observations are of high local interest 
in Louisville and surrounding areas since 
there is a large rubber manufacturing plant 
in our community.  As a result, urban air in 
areas of Louisville contains several times 
the EPA permissible limit of butadiene. 
While butadiene, which is also a component 
of cigarette smoke, is well known to cause 
cancer and trigger asthma, the realization that 
it could cause heart disease adds new interest 
in regulating its emissions and limiting 
exposure.  The notion that chemicals such as 
butadiene could accelerate atherosclerosis is 
supported by animal studies which show an 
increase in atherosclerotic lesion formation 
upon exposure (18).  Interestingly, these 
studies show that the amount of butadiene 
required to increase heart disease was much 
lower than that to cause cancer, suggesting 
that an increase in heart disease may be a more common 
or frequent outcome than cancer in people exposed to such 
chemicals.  A similar increase in the risk for heart disease 
has been shown for workers exposed to vinyl chloride, which 
is another chemical used in the rubber industry.  A seven-
year study of 1,100 vinyl chloride exposed workers showed 
that exposure to vinyl chloride significantly increases the 
prevalence of high blood pressure and the incidence of heart 
attack (19).
While neither butadiene nor vinyl chloride is an aldehyde, 
we believe that the ultimate toxicity of these pollutants 
is related to their conversion to aldehydes. Both these 
compounds are metabolized by the body which converts them 
to aldehydes and these aldehydes are in turn responsible for 
the adverse cardiovascular effects associated with exposure 
to vinyl chloride or butadiene.  The main reason for concern 
that aldehyde exposure could increase disease risk is that, 
by their very nature, some of these aldehydes are highly 
toxic.  When delivered intravenously to animals, aldehydes 
in low doses (1-10 mg/kg) prolong Q-T interval and cause 
TABLE 3
Table 3:  Levels of aldehydes in mainstream smoke of reference cigarettes
TABLE 2
Table 2:  Composition of aldehydes present in automobile exhaust
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arrhythmias and ventricular fibrillation.   Depending on 
the dose, they could increase or decrease blood pressure 
(6). Aldehydes that stimulate stress responses or hormones 
increase blood pressure, however, by themselves they lower 
blood pressure. Indeed, one symptom of acute formaldehyde 
poisoning is a rapid fall in blood pressure, causing flushing, 
dizziness or even death.  
Chronic exposure to aldehydes could have further 
adverse effects on cardiovascular health. For instance, it has 
been shown that animals fed aldehydes for several months 
develop hypertension, increase platelet calcium and show 
an increase in their heart weight, which is usually associated 
with poor cardiac performance (6).  Aldehydes also inactivate 
important enzymes in the plasma which interferes with the 
function of HDL (the “good” cholesterol) and thus could 
elevate the risk of developing heart disease.  Although such 
data strengthen the rationale for studying the cardiovascular 
effects of aldehydes, there is no firm evidence suggesting 
that humans exposed to aldehydes are at a greater risk for 
developing heart disease.  However, our studies with animals 
exposed to aldehydes are beginning to provide some insights 
into how aldehydes could affect cholesterol levels, alter blood 
pressure and decrease the ability of the heart to protect itself 
from ischemia.  Much work remains to be done, particularly 
in establishing the relevance of animal studies to human 
conditions.
Despite several unknowns in regard to the toxicologic 
nature of specific pollutants, it is clear that air pollution from 
current patterns of fossil fuel use is seriously affecting the 
health of millions of people worldwide. In addition, pollutants 
such as arsenic have caused arguably the worst toxicological 
disaster in human history in several developing countries 
(20-22).  That air pollution could negatively impact human 
health is well established, however, the surprising feature 
of these new findings is that an increase in heart disease is 
the most significant and widespread outcome of pollutant 
exposure. This is borne out not only by the extensive burden 
of heart disease due to tobacco use, but also by significant 
increases in cardiovascular diseases in populations exposed 
to pollutants such as arsenic and ambient air particulates. 
Collectively, even by conservative estimates, pollution may 
be contributing to cardiovascular disease in several million 
individuals.  These estimates underscore the urgent need to 
identify and control individual components of pollution that 
affect the heart and blood vessels. Studies underway aimed at 
determining how pollution affects heart disease will continue 
to enlighten and remind us of how delicate and entwined our 
health is with our environment.
Bradford Hill is a graduate student in the Program in 
Biochemistry & Molecular Biology and is a trainee with 
Aruni Bhatnagar, Professor of Medicine/Cardiology and 
Biochemistry & Molecular Biology.  Oleg Barski is an 
Assistant Professor of Medicine/Cardiology.
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Questions in Environmental Cardiology
Environmental cardiology raises a special set of 
toxicological questions concerning the interactions of 
xenobiotics and the cardiovascular system, including:
• What are the identities of the xenobiotics to which 
people are exposed?
• What is the nature of the exposure event? (Acute? 
Chronic? To what doses and by what routes are they 
exposed?)
• What is the fate of the xenobiotics when they enter the 
body?  Where do they go?  What are they changed to? 
How are they eliminated?
• What is the nature of the host-xenobiotic interaction? 
What new molecules are formed and what are their 
effects?
In order to study these phenomena at the molecular level, 
sophisticated tools are needed.  Of course, cardiopulmonary 
medicine and related disciplines already provide tools of 
electrophysiology and sonography for study of physiological 
function that may be compromised by xenobiotic exposure. 
To study the suspect molecules from the environment, we 
have available the tools of analytic chemistry, especially 
those of chromatography and spectrometry.
The key molecules for study in environmental cardiology 
are those that result from biotransformation (metabolism) 
of xenobiotics and also newly formed molecules that result 
from chemical reaction of a xenobiotics or its derivative with 
proteins, nucleic acids (DNA, RNA), lipids (fats that make up 
much of biological membranes) and other biomolecules.
The development of tools needed for sophisticated 
analysis of the interactions between xenobiotics and 
complex biomolecules has undergone an explosion over 
the last generation.  These tools include newly developed 
techniques in chromatography and electrophoresis, but 
the most important changes have been in application of 
the techniques of mass spectrometry to the questions of 
biomedical research.
Mass Spectrometry and its Development
Mass spectrometry (MS) has been used since the first 
experiments of J.J. Thompson in 1899 .   In studying “positive 
rays”, Thompson was able to maneuver such radiation with 
electromagnetic fields and to measure mass  (For a brief 
history, visit the Scripps website  http://masspec.scripps.
edu/information/history/ ).  Even to this day, the fundamental 
mode of operation of mass spectrometry remains the same 
as shown schematically in Figure 1:
Not magic, but mass spectrometry to monitor interactions of 
environmental pollutants and the cardiovascular system
William M. Pierce, Jr, Jian Cai, Ned Smith,
Delano Turner, Kevin G. Taylor and Jason R. Neale,
Department of Pharmacology, Biomolecular Mass Spectrometry Facility,
Department of Medicine, University of Louisville, Louisville, KY.
Abstract.
As environmental cardiology continues to emerge as a subdiscipline, the tools of cardiovascular medicine and physiology 
are integrated with the tools of toxicology and epidemiology.  For molecular level studies, the most powerful tool available 
is that of biomolecular mass spectrometry.  This is a discussion of the historical developments and current applications of 
mass spectrometry that enable such use.  Mass spectrometric techniques and analytical strategies are shown to be useful in 
molecular dosimetry studies, toxicokinetics and studies of mechanisms of action. Cardiovascular disease (CVD) is the number 
one cause of death in most developed countries, accounting for more deaths in 2001 in the United States than cancer, diabetes 
and accidents combined (Weinhold, 2004.) As with other diseases, a variety of causes can predispose or cause CVD, including 
genetic predisposition, as well as lifestyle factors which are more controllable, including diet, exercise and other good health 
care habits.  In contrast to, for example, cancer, relatively little research has been accomplished examining potential roles of 
foreign compounds (xenobiotics) in causing or exacerbating CVD. The newly emerging field of environmental cardiology 
is beginning to address this area, with particular focus on the interactions of common xenobiotics encountered in developed 
urban settings, such as chemical pollutants derived from various manufacturing and shipping processes and products of 
combustion, including reactive xenobiotics, gasses, vapors and particulates.  Some of these are known or suspected in the 
etiology of CVD.
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Mass spectrometers are particularly useful because they 
are universal detectors.  That is, the only requirement for 
an analyte is that it be made of matter.  Mass spectrometers 
analyze matter in the gas phase in a charged state (ions). 
These ions (either positive or negative) are either introduced 
or produced in the ion source region.  By applying a large 
voltage in this region, ions acquire kinetic energy and are 
accelerated through the mass analyzer.  There are several 
types of mass analyzers which serve to measure, directly or 
indirectly, the momentum of these ions as they travel from 
source to detector.  Momentum and kinetic energy are related 
directly to mass, and an attached data system is able to acquire 
data concerning the mass of these ions.
As we consider xenobiotics and biological molecules, it 
would seem that mass is not a unique identifying property. 
For example, nitrogen gas (N2) and carbon monoxide (CO) 
each has a nominal molecular mass of 28 (14+14 or 12+16). 
What we have learned from chemistry, however, is that 
atoms do not have exactly integral mass values, and for this 
example, the true masses are for CO 27.995 and for  N2, m/z 
28.006.  Many mass spectrometers can readily measure this 
difference and thus can distinguish the two gasses.  This is 
equivalent resolution to that required to distinguish a 150 
pound individual from another who weighs 150.06 pounds. 
In addition to this ability to measure masses very accurately, 
mass spectrometers have a very wide dynamic range, capable 
of mass measurement up to molecular masses of millions of 
Daltons.  
To be useful for studies of part per billion pollutants 
diluted into 50-100 kg animals (adult humans), mass 
spectrometers must be very sensitive, able to measure small 
amounts of analyte.  This is indeed the case, with some MS 
instruments capable of measuring 1000 or fewer molecules. 
This is very few indeed, as can be shown by a simple thought 
experiment.  Take the U.S. national debt ($8.2 trillion and 
counting) and give that much money to every man, woman 
and child on the planet (6.58 billion and counting.)  Try to 
imagine that amount of money, then realize that a teaspoonful 
of water has twice that many molecules of water!
Mass spectrometers have one more capability which 
gives them enormous power in structural analysis.  Not only 
are MS instruments able to sensitively and accurately measure 
the mass of the molecules introduced into the ion source, but 
these instruments usually have a means for exciting analyte 
molecules to induce decomposition into fragments of these 
molecules.  The masses of these fragments can be determined. 
This pattern is similar to a fingerprint, allowing one to deduce 
the structure of the analyte.
This ability to identify unknown compounds from crude 
mixtures of traces of analyte has lent a mystique to the use 
of mass spectrometry as a “magic black box” capable of 
detecting anything.  Earlier television programs such as 
Quincy, M.E., and current programs such as C.S.I. and Law 
and Order are wildly popular, and often rely on the use of 
mass spectrometers.  A small drop of fluid is introduced into 
the instrument (Figure 2) and instantly, a pattern of peaks 
appears on a computer screen, followed by dialog like, “This 
spectrum clearly shows that the perp stopped at a truck stop 
in Tucson, had a bagel with apricot preserves and a skinny 
mocha latte immediately before raping and murdering Ms. 
Smith, who was wearing a lavender seersucker suit and 
chewing cinnamon gum at that time.”
“That’s it, Johnson is our man.  Bring him in.”
While this is very successful entertainment, it bears 
no resemblance to reality, and actually creates exaggerated 
expectations for mass spectrometry.
Figure 1.  Schematic mass spectrometer.  Although modern mass spectrometers 
are marvels of engineering, ion physics and chemoinformatics, the fundamentals 
remain the same.
Figure 2.  A whimsical example of using MS technology as “black box 
magic.”  
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Modern Biomolecular Mass Spectrometry
All of the properties discussed above were available to 
scientists in the 1950s, yet biomolecular mass spectrometry 
(the application of MS to study of biomolecules) has only 
recently become commonplace.  That is because such 
application awaited several developments in companion 
sciences.
Several advances in technology and prevailing  scientific 
paradigm since the 1980s have enabled everyday use of mass 
spectrometry in biomedical sciences. These contributions are 
shown schematically in Figure 3.  
Early mass spectrometers had paper strip output and 
mass assignments were made using a mix of pencils, rulers, 
graduate students and coffee.  Although tedious, no other 
method could rival this.  Modern mass spectrometers are 
operated using high speed computers with vast data storage 
capabilities, allowing sample collection in the GHz range 
(billions of scans per second.)    Dramatic advances in 
data handling, and studies of very large data sets (see large 
scale biology below) have been the impetus for the rapid 
demand and growth in the fields of chemoinformatics and 
bioinformatics.  These are disciplines which develop and 
use computational and statistical analysis of large data sets 
to infer chemical and biological meaning. 
The need for new tools and approaches of informatics 
became very clear as the human genome project developed. 
The very large sets of data available were powerful tools in 
the hands of those able to use them.  For this project, the 
goal was definition of the entire human genome – that is 
the structure of all of the genes and chromosomes.  As this 
unfolded, other scientists argued that the relatively static 
genome serves as a blueprint, and while it is important, the 
complementary proteome (the structure of all of the proteins 
in a cell) is important in understanding regulatory biology. 
This is because the proteins are the molecules that provide 
structure in the cell and the proteins serve as catalysts to 
manage the chemical reactions within a cell.  Finally, the 
discipline becoming known as metabolomics completes the 
picture, seeking to take a moment-to-moment snapshot of the 
smaller molecules (metabolites) in the cell.  The attempt to 
study all of these phenomena simultaneously is called systems 
biology.  Mass spectrometry is one of several technologies 
critical to this field.
The key technical advancement that has enabled 
biomolecular mass spectrometry is the development of so-
called soft ionization techniques.  Earlier MS instruments 
were not useful for proteins, nucleic acids, carbohydtaes 
and the like because of the harsh conditions used for 
vaporization, ionization or both.  With the development of 
electrospray ionization (ESI) methods and laser desorption 
ionization (LDI) methods, this barrier was removed.   These 
developments were sufficiently significant that John B. 
Fenn of Virginia Commonwealth University (ESI) and 
Koichi Tanaka of Shimadzu Corporation (LDI) received 
a portion of the 2002 Nobel Prize in Chemistry “for their 
development of soft desorption ionisation methods for mass 
spectrometric analyses of biological macromolecules.”   Later 
work at the University of Frankfurt by Franz Hillenkamp and 
Michael Karas led to the development of a matrix.  It is the 
development of ESI and MALDI that opened the door for 
biology to use mass spectrometry.
Aldehyde Pollutants and Analytical Strategy
Of the 300,000 or so sudden cardiac deaths each year, it 
is estimated that perhaps 20% are due to acute air pollution 
exposure.  The cause and effect relationship, as well as the 
mechanisms of action are not clear.
The Environmental Cardiology team at the University 
of Louisville is examining a particular chemical class, the 
aldehydes, for their effects on molecular, cellular or systemic 
function.  Aldehydes are a group of chemicals that can be 
found in high quantities in vehicle exhaust fumes and cigarette 
smoke. In this context, they are the products of incomplete 
combustion.  In addition, these chemicals are also found in 
fried foods, fats and drinking water.  The projects currently 
underway seek answers to four basic questions regarding the 
cardiotoxicity of aldehydes:
Figure 3.  Scientific and technological changes since the 1980s have enabled 
everyday use of mass spectrometry in biomedical sciences.
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Figure 4.  For this analysis of a single tissue extract, more than 4000 mass 
spectra were obtained. Each peak in this chromatogram corresponds to a 
single compound which can be identified by mass spectrometry (Srivastava 
et al., 1998).
• How do cardiovascular tissues metabolize aldehydes 
and how does the cardiovascular system handle the 
challenge of foreign chemicals? 
• How, and how quickly, do aldehydes accelerate the 
progression of heart disease? 
• How do aldehydes interact with blood cells to cause 
cardiac and vascular inflammation? 
• How do high levels of aldehydes raise the risk of heart 
attack and worsen heart failure? 
The principal uses of mass spectrometry for molecular 
level analysis for these projects are in the areas of (1) 
molecular dosimetry, (2) toxicokinetics and metabolism and 
(3) mechanisms of toxicity.
Molecular Dosimetry
All of us are frequently exposed to a variety of aldehydes, 
from the environment (foods, water, air) and from normal 
metabolism, especially that of fats.  These projects focus 
on the more highly reactive αβ unsaturated aldehydes, and 
particular attention will be paid to hexenal, 9-hydroxynonenal 
and acrolein.  The need for a molecular dosimeter (a molecule 
whose presence and concentration reflect exposure) is 
several-fold.  It is important to be able to mimic exposures 
that are realistic in comparison to real human exposures.  It 
is important to know how to correlate exposure to risk of 
toxicity.  It is important to have an analysis that allows us to 
monitor human exposure and to identify people at risk for 
developing cardiotoxicity.  Finally, it is equally important 
to develop an analysis that can provide, with confidence, a 
means of reassuring the “worried well”, those with potential 
exposure to aldehyde sources or at risk for cardiotoxicity who 
have not sustained a toxic exposure.
For molecular dosimetry and for inhalation toxicology 
in vivo we will develop a molecular dosimeter that will do 
one of the following:
• Quantitative measurement of acrolein in blood plasma 
using gas chromatography/MS  analysis, or
• Quantitative measurement of small molecule that 
serves as “sink” for acrolein, but is readily excreted 
(for example, ascorbate or glutathione)
• Quantitative measurement of an extracellular protein 
that serves as “sink” for acrolein (this may be any 
abundant plasma protein)
These studies will be accomplished using GC/MS and 
LC/MS.
Toxicokinetics
For toxicokinetics, this project will identify and quantify 
metabolites of αβ unsaturated aldehydes,  will study the rate 
of elimination of parent compound and metabolites, and will 
monitor especially those formed with ethanolamine, globin 
or albumin.
Mechanistic Studies
For mechanistic studies, understanding of chemistry of 
reactions of αβ unsaturated aldehydes and identification of 
targets will result in the following:
• Studies of mechanisms and kinetics of reactions of αβ 
unsaturated aldehydes and model peptides
• Performance of expression proteomics experiments to 
identify candidate proteins
• Use of cardiovascular function tests to suggest 
candidate protein targets
• Studies of mechanisms and kinetics of reactions of 
αβ unsaturated aldehydes and candidate proteins or 
nucleic acids
Analytical Strategies
Given the rich variety of mechanisms and potential 
number of target molecules, there are only a few different 
types of studies that will be performed.  In anticipation 
of animals exposed via the inhalation route, preliminary 
experiments have been performed to demonstrate feasibility. 
These analyses are designed to study the fate of aldehyde air 
pollutants in the body: (1) GS/MS analysis for low molecular 
weight and volatile analytes, (2) expression proteomics, 
(3) model peptides and aldehyde reactivity, (4) MS protein 
analysis for identification of proteins and sites of adduct 
formation and (5) methods for analysis of DNA adducts.
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GC/MS Analysis of low molecular weight species.
Methods for analysis of aldehydes using GC/MS have 
been published by this group and an example chromatogram 
is shown in Figure 4.  In principle, each of these peaks can 
be identified using mass spectrometry.
GC/MS analyses are useful for a variety of applications 
in these projects.  Examples include:
• Direct dosimetry – for some airbourne pollutants, 
measurement of the amount in the bloodstream will 
be the best measure of the delivered dose of the 
xenobiotics.  Alternatively, endogenous metabolite 
adducts (lipids, carbohydrates, etc.) may be identified 
this way
• Exposure and risk – if this is indeed useful as a measure 
of delivered dose, then workers in the chemical 
industry, neighbors of such industry and others will 
have a simple test availale to demonstrate such 
exposure, which will guide treatment.
• The “worried well” – in the case of known or purported 
exposure to an area, there will almost always be a large 
group of the “worried well” those at risk who have not 
experienced significant exposure or risk.  These can be 
reassured by negative findings of such tests.
MS Analysis of Protein-Adduct formation
Many xenobiotics are sufficiently reactive that they will 
form adducts with endogenous proteins.  Such adducts are 
useful “biomarkers” of exposure.  MS techniques are useful 
for discovery and monitoring of such biomarkers.
Model peptides and aldehyde reactivity - One approach is 
to study the chemistry of the reactivity of known aldehydes. 
Studies using acrolein and hydroxynonenal (HNE) have 
shown that the unsaturated aldehydes are indeed highly 
reactive toward peptide thiols and primary amines.  For the 
following group of peptides and reactivity toward acrolein, 







Expression proteomics - One way to discover useful 
biomarkers formed as adducts of aldehydes is to attempt to 
study all available proteins from a tissue, before and after 
exposure to air pollutants.  Data shown below in Figure 5 are 
from a report of the use of protein mass spectrometry to study 
oxygen sensitive pathways in regulatory biology.  In this 
study, expression proteomics analysis using two dimensional 
electrophoresis and mass spectrometry was able to identify 
several altered proteins.  After electrophoretic separation, 
each protein can be taken for MALDI peptide fingerprinting 
or further structural analysis.
Figure 5.  Proteins were extracted from tissues samples and separated using high 
resolution 2D PAGE analysis followed by MALDI-TOF mass spectrometric analysis 
of tryptic digests.  Red dots designated protein “spots” that were identified using 
mass spectrometric patterns.  Yellow spots have been selected for continuing 
study because the expression level is either higher or lower than control, but 
initial studies failed to identify them (Gozal et al., 2002)
Figure 6 
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Peptide fingerprinting and partial sequencing
The use of MS techniques to identify proteins and study 
their structure, especially in cases of large scale biology 
design, is to obtain as much information as possible as 
efficiently as possible.  Often a three tiered approach is used, 
as shown in Figure 6.
For peptide mass fingerprinting, a sample (usually 
excised from a gel or in solution as a column effluent) is 
treated with an endoproteinase, such as trypsin, which cleaves 
the protein into a few dozen smaller peptides.  These are 
typically analyzed using MALDI and time-of-flight MS. 
The data obtained are the masses of the peptides.  Since we 
know where the enzymes cleave (trypsin leaves an arginine 
or lysine on the carboxy terminus), we can go to a protein 
data base, and compare our data to all of the known proteins. 
A laboratory can perform hundreds of such analyses per 
day.  Any adduct formed will have an altered mass and can 
be tentatively identified.  If this approach is inadequate, 
tandem MS (two in-line MS systems) is used to determine 
the sequence of one or more peptides.  Some proteins have 
as many as 500-1000 amino acid residues and typically 
no effort is made to determine all of these in a de novo 
sequencing study.  If 7 consecutive residues in a peptide 
can be determined (this is often readily accomplished), 
this sequence can be used to interrogate a known genome 
(such as homo sapiens) asking he question “Where is this 
sequence found?”  Even though this is a minor fraction 
of the protein’s sequence, the random chance of finding 7 
consecutive residues is less than 1 in a billion (207)!  If this 
fails, de novo sequencing may be necessary.  Combinations 
of these techniques yield identification of the protein, of the 
adduct and the site and amount of adduct formation.
As data accumulate concerning which proteins are 
modified by exposure to environmental compounds, molecular 
mechanisms can be deduced.  For example, changes in 
inflammatory pathway proteins and/or lipid carrying proteins 
are likely to influence plaque formation and may increase 
the risk of myocardial infarction or stroke.  Modifications 
of excitable cardiac tissue proteins or signal transduction 
proteins may lead to dysrhythmmias.  Modifications of 
cytoskeletal proteins may underlie diminished cardiac output. 
This is the point for integration of physiological data and 
molecular level findings.
MS analysis of DNA-xenobiotic adducts 
Reactive xenobiotics may form adducts with DNA as 
well.  In some cases this will lead to diminished cell function, 
in others, to apoptosis or necrosis and in the worst cases, a 
mutagenic and ultimately a carcinogenic effect.
To examine this possibility, DNA samples were 
hydrolyzed to yield nucleosides, then taken for LCMS 
analysis to elucidate the structure of the aminobiphenyl 
adduct of deoxyguanosine as shown in Figure 7. (Neale, 
J.R., unpublished data.)Such analyses allow prediction or 
verification of mechanisms of toxicity.
While mass spectrometry is not a magical black box that 
can discover and prove everything (sorry CSI!) it is a very 
valuable tool for elucidation of toxicological mechanisms in 
environmental cardiology.
William M.Pierce, Jr. is Professor of Pharmacology 
& Toxicology and Director of the Biomolecular Mass 
Spectrometry Facility at the University of Louisville.  J. Cai 
is an Assistant Professor of Pharmacology and Technical 
Director of the Biomolecular Mass Spectrometry facility. 
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